MBX - CIK 0001776111
MBX Biosciences, Inc. has filed 198 documents with the SEC between 2019 and 2026. The most frequent type is insider trade (58 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-12 | - |
| SCHEDULE 13D/A | - | 2025-11-10 | - |
| Insider trade | 4 | 2025-11-07 | 2025-11-06 |
| Securities registration | S-3 | 2025-11-06 | - |
| Quarterly report | 10-Q | 2025-11-06 | 2025-09-30 |
| Major company event | 8-K | 2025-11-06 | 2025-10-31 |
| Insider trade | 4 | 2025-10-28 | 2025-10-24 |
| Insider trade | 4 | 2025-10-21 | 2025-10-20 |
| Insider trade | 4 | 2025-10-20 | 2025-10-17 |
| SCHEDULE 13G/A | - | 2025-10-06 | - |
| SCHEDULE 13D/A | - | 2025-09-30 | - |
| SCHEDULE 13D/A | - | 2025-09-30 | - |
| Insider trade | 4 | 2025-09-30 | 2025-09-26 |
| SCHEDULE 13D/A | - | 2025-09-30 | - |
| Major company event | 8-K | 2025-09-26 | 2025-09-24 |
| 424B4 | - | 2025-09-25 | - |
| EFFECT | - | 2025-09-24 | - |
| S-1MEF | - | 2025-09-24 | - |
| Company correspondence | CORRESP | 2025-09-22 | - |
| Company correspondence | CORRESP | 2025-09-22 | - |
| IPO registration | S-1 | 2025-09-22 | - |
| Major company event | 8-K | 2025-09-22 | 2025-09-22 |
| Major company event | 8-K | 2025-09-04 | 2025-09-04 |
| SCHEDULE 13D/A | - | 2025-08-20 | - |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SEC correspondence | UPLOAD | 2025-08-13 | - |
| SCHEDULE 13G/A | - | 2025-08-12 | - |
| DRS | - | 2025-08-08 | - |
| Quarterly report | 10-Q | 2025-08-07 | 2025-06-30 |
| Major company event | 8-K | 2025-08-07 | 2025-08-07 |
| Major company event | 8-K | 2025-06-16 | 2025-06-16 |
| Major company event | 8-K | 2025-06-09 | 2025-06-09 |
| Insider trade | 4 | 2025-06-06 | 2025-06-05 |
| Insider trade | 4 | 2025-06-06 | 2025-06-05 |
| Insider trade | 4 | 2025-06-06 | 2025-06-05 |
| Insider trade | 4 | 2025-06-06 | 2025-06-05 |
| Insider trade | 4 | 2025-06-06 | 2025-06-05 |
| Insider trade | 4 | 2025-06-06 | 2025-06-05 |
| Insider trade | 4 | 2025-06-06 | 2025-06-05 |
| Major company event | 8-K | 2025-06-06 | 2025-06-05 |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |
| Major company event | 8-K | 2025-05-12 | 2025-05-12 |
| SCHEDULE 13G/A | - | 2025-05-12 | - |
| Annual report to shareholders | ARS | 2025-04-23 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-23 | - |
| Proxy statement | DEF 14A | 2025-04-23 | 2025-04-22 |
| Insider trade | 4 | 2025-04-10 | 2025-04-08 |
| Insider trade | 4 | 2025-04-09 | 2025-04-07 |
| New insider ownership | 3 | 2025-04-07 | 2025-04-07 |